Guangzhou Alpha Omega Medical Technology, an Israeli medical device company specializing in neurosurgery and neuroscience, recently received 50 million yuan ($7.27 million) in investment from Guangzhou Sino-Israel Bio Industry Investment Fund.

The money will be used to establish an innovation center in Guangzhou, which will be designed to integrate the expertise of scientists, doctors and companies, according to a Guangzhou Daily report.

The investment is Alpha Omega's first external funding.

The company was founded in 1993 and has a global staff of 85, including nine in Guangzhou, a medical hub in South China.

The choice to partner with Guangzhou is based on its excellent education system, universities and talent, financial and government support, and the infrastructure in the Guangzhou International Bio Island, where the innovation center is located, said Samer Abboud, CEO of Guangzhou Alpha Omega Medical Technology.

Samer Abboud, CEO of Guangzhou Alpha Omega Medical Technology. [Photo provided to chinadaily.com.cn]